XIST |
Xq13 |
Up |
Oncogenic |
Intergenic |
XIST functioned as an oncogene in NPC through up-regulating E2F3 in part through ‘spongeing’ miR-34a-5p |
[63] |
lncRNA-ROR |
18q21 |
Up |
Oncogenic |
Intergenic |
Suppress p53 signal pathway and promotes proliferation, migration and chemoresistance |
[69] |
AFAP1-AS1 |
4p16.1 |
Up |
Oncogene |
Antisense |
Inhibit AFAP1 protein expression and affected the expression of several small GTPase family members and molecules in the actin cytokeratin signaling pathway. promoted cancer cell metastasis via regulation of actin filament integrity |
[9] |
Hotair |
12q13.13 |
Up |
Oncogene |
Antisense |
Hotair promoted angiogenesis through directly activating the transcription of angiogenic factor VEGFA as well as through GRP78-mediated upregulation of VEGFA and Ang2 expression |
[8] |
HNF1A-AS |
12q24.31 |
Up |
Oncogene |
Antisense |
Promoted proliferation, migration and EMT |
[37, 70] |
lncRNA-LET |
15q24.1 |
Down |
Tumor suppressor |
Intronic |
inhibited NPC cells proliferation and induced cell apoptosis, transcriptional repressed by EZH2-mediated H3K27 histone methylation on the LET promoter |
[71] |
H19 |
11p15.5 |
Up |
Oncogene |
LincRNA |
Inhibited E-cadherin expression and promoted invasion via the mir-630/EZH2 pathway |
[54] |
NEAT1 |
11q13 |
Up |
Oncogene |
Sense |
Regulated EMT phenotype and radioresistance by modulatin themir-204/ZEB1 axis |
[22] |
MALAT1 |
11q13.1 |
Up |
Oncogene |
Sense |
Regulated CSC activity and radioresistance by modulating mir-1/slug axis |
[23] |
LOC401317 |
NA |
Up |
Oncogene |
NA |
Inhibited cell proliferation and induced apoptosis |
[10] |
LINC00312 |
3p26 |
Down |
Tumor suppressor |
Intergenic |
NA |
[72] |